Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Immunogenetics of Childhood Type 1 Diabetes in Immigrant Patients in Sweden. Migration Studies on Type 1 Diabetes

Author

  • Ahmed Delli

Summary, in English

This thesis examined whether the offspring of immigrants (non-Swedes) to Sweden are at increased risk of Type 1 Diabetes (T1D) when they are born or live in Sweden. It also evaluated if their T1D and T2D-related genes differed from Swedish patients and whether this genetic heritage determined the types and existence of islet autoantibodies at time of diagnosis and affected the classification of diabetes.

A total of 3451 (55% males) newly diagnosed T1D patients (<18 y) were recruited from the Better Diabetes Diagnosis (BDD) study. We calculated the “patients/105/y” rate of confirmed T1D, which was 14 (95%CI: 13-15) among non-Swedes (8% of total) compared to 22 (95% CI: 21-23) for Swedes (66%). The rate for non-Swedes was at least 2 times higher than the mean incidence rates for countries of parents’ origins. Non-Swedes had predominately GAD65A (64%) in association with DQ2, which prevailed in the non-Swedes (34%, OR=1.5) compared to Swedes (15%). The Swedes had more multiple (>=2) autoantibodies and IA-2A in association with the dominant DQ8 and 2/8. The ZnT8-WA (38%) found less in non-Swedes compared to Swedes (50%), consistent with lower frequency in the non-Swedes (37%) of the SLC30A8 CT+TT than in Swedes (54%). The ZnT8-RA (57% and 58%, respectively) did not differ despite a higher frequency of CC (RR) genotypes in non-Swedes (63%) compared to Swedes (46%). In non-Swedes only, the prevailing DQ2/X (40%) compared to Swedes (14%) was negatively associated with ZnT8-WA (p=0.008) and ZnT8-QA (p=0.03) but not ZnT8-RA (p=0.26). Molecular simulation showed non-binding of the relevant ZnT8R peptide to DQ2 explaining in part the possible lack of tolerance to ZnT8-R by DQ2. The DQ8 and DQ6.4 had stronger binding epitopes outside the polymorphic site at amino acid position 325. The INS-SNP rs689 A/A genotype contributed T1D risk in non-Swedes (65%), though less than Swedes (72%). IAA were predicted by A/A (OR=3.5) but negatively associated with increasing age at diagnosis (OR=0.1) and HLA-DQ2 regardless of ethnic background (OR=0.6) explaining, in addition to INS T/T, the lower IAA in non-Swedes. In the

Swedes only, IAA were associated with DQ2/8 (40%) and 8/x (32%), which were also stronger predictors of IAA at a younger age than INS genotypes. Non-Swedes were further subdivided into non-Europeans (n=148, 63%) and European-descent (n=86, 37%). Non-European had less T1D risk genes (HLA DQ and PTPN22) and more T2D risk genes (SLC30A8 and FTO genes), therefore they were more prone to be autoantibody-negative (11% compared to 8% in Europeans and 6% in Swedes)and had less multiple autoantibodies (64%% compared to 81% in Europeans and 79% in Swedes).

Our data suggest that immigrants from low incidence countries (80% were born in Sweden), especially non-Europeans, are exposed to higher T1D in Sweden, because their genetic heritage affected by the Swedish environment. Non-European immigrants develop T1D in Sweden with lesser T1D-related genes but more T2D-related genes and less islet autoantibodies when compared to Europeans and native Swedes.

Department/s

  • Diabetes and Celiac Unit
  • LUDC (Lund University Diabetes Centre)-lup-obsolete
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2012

Language

English

Publication/Series

Lund University Faculty of Medicine Doctoral Dissertation Series

Volume

2013:14

Document type

Dissertation

Publisher

Department of Clinical Sciences, Lund University

Topic

  • Clinical Medicine

Keywords

  • Diabetes
  • Type 1 Diabetes
  • Childhood
  • Human Leukocyte Antigen (HLA)
  • Islet autoantibodies
  • Zinc Transporter 8 (ZnT8)
  • Islet antigen (IA2-)
  • Glutamic Acid Decarboxylase 65 (GAD65
  • Insulin
  • Migration.

Status

Published

Research group

  • Diabetes and Celiac Unit
  • LUDC (Lund University Diabetes Centre)-lup-obsolete

Supervisor

  • Åke Lernmark
  • Bengt Lindblad
  • Annelie Carlsson

ISBN/ISSN/Other

  • ISSN: 1652-8220
  • ISBN: 978-91-86871-76-5

Defence date

17 February 2012

Defence time

13:00

Defence place

Jubileumsaulan, entrance 59, Skåne University Hospital (SUS), Malmö.

Opponent

  • Geir Joner (Professor)